Pfizer Inc.'s first-quarter earnings rose a bigger-than-expected 10% as the pharmaceutical giant reported fewer charges, though revenue edged down amid slumping Lipitor sales. Shares of Pfizer, which affirmed its 2011...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Pfizer Profit Rises 10%
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account